The evolving understanding of histology as an endpoint in ulcerative colitis
- Author:
Shintaro AKIYAMA
1
;
Yusuke MIYATANI
;
David T. RUBIN
Author Information
- Publication Type:Review
- From:Intestinal Research 2024;22(4):389-396
- CountryRepublic of Korea
- Language:English
- Abstract: A therapeutic goal for patients with ulcerative colitis (UC) is deep remission including clinical remission and mucosal healing. Mucosal healing was previously defined by endoscopic appearance, but recent studies demonstrate that histological improvements can minimize the risks of experiencing clinical relapse after achieving endoscopic remission, and there is growing interest in the value and feasibility of histological targets of treatment in inflammatory bowel disease, and specifically UC. In this review article, we identify remaining challenges and discuss an evolving role of histology in the management of UC.
